| Name | Title | Contact Details |
|---|
The Ninety Nine Restaurant & Pub is headquartered in Woburn, Massachusetts, and has earned a strong reputation as a friendly, comfortable place to gather and enjoy great food and great drink at a terrific price. With the establishment of the Ninety Nine Restaurant & Pub in 1952, founder Charlie Doe created an entirely new niche in the New England hospitality industry – the casual restaurant – long before the appearance of others. The Ninety Nine Restaurant & Pub continues to prosper and grow. The Ninety Nine updates and refines its menu on an ongoing basis to provide guests with fresh new options, yet continues to offer great food and great drink at a terrific price. This philosophy began when the company was founded, and is still maintained today. The culture at the Ninety Nine Restaurant & Pub was instilled by Charlie Doe long before a mission statement was ever written down on paper. But the proclamation means that guests, team members, community and stakeholders are treated with respect. For guests, it means they have a friendly, comfortable place to gather and enjoy great food and great drink at a terrific price. The Ninety Nine is proud to serve more than 20 million customers a year in over 105 restaurants throughout the Northeast. For team members it translates into accommodating work schedules, generous benefits, including 401(k) plans and health, life and dental insurance (for hourly and part-time team members as well); and plentiful rewards for top performers.
Starr Insurance is a prominent part of Starr Companies, a global insurance and investment organization founded in 1919 by Cornelius Vander Starr. Initially established as the first American-owned insurance agency in Shanghai, the company has grown to operate across six continents, becoming a significant player in the insurance industry. Starr Insurance offers a diverse range of products and services, including commercial property and casualty insurance, as well as specialty coverages such as aviation, marine, energy, and excess casualty insurance. The company serves a wide array of clients, including leading businesses in sectors like construction, maritime, energy, and aerospace. With its extensive global presence, Starr Insurance is well-equipped to provide comprehensive insurance solutions tailored to the needs of businesses worldwide.
BNP Paribas is a leading bank in Europe with an international reach. It has a presence in 65 countries, with more than 190,000 employees, including more than 145,000 in Europe. BNP Paribas holds leading positions in its three major operating divisions: ⚆ Commercial, Personal Banking & Services for all the Groups retail banking networks and several specialised businesses, including BNP Paribas Personal Finance and Arval; ⚆ Investment & Protection Services for savings, investment and protection solutions; ⚆ Corporate & Institutional Banking, which is focused on corporate and institutional clients. The Group helps all its clients (individuals, community associations, entrepreneurs, SMEs, corporates and institutional clients) to realise their projects through solutions spanning financing, investment, savings and protection insurance. In Europe, the Group has four domestic markets (Belgium, France, Italy and Luxembourg) and BNP Paribas Personal Finance is the European leader in consumer lending. BNP Paribas is rolling out its integrated retail-banking model in Mediterranean countries, in Turkey, in Eastern Europe and a large network in the western part of the United States. In its Corporate & Institutional Banking and Investment & Protection Services activities, BNP Paribas also enjoys top positions in Europe, a strong presence in the Americas as well as a solid and fast-growing business in Asia-Pacific. To learn more about our social media terms and Data Protection Notice: https://group.bnpparibas/en/data-protection
In 1954, in a one-room machine shop in Augusta, Georgia, the first Textron Specialized Vehicles products were born. Two brothers started with a simple belief that they could build a better golf car, that better met the customers needs, than any other vehicle on the market. Since those beginnings, the Textron Specialized Vehicles product line includes not only golf cars, but also ground support equipment for the aviation industry, industrial utility vehicles, and recreational side-by-side UTVs. The company has become a world leader in transportation and a leading global manufacturer of golf cars, side-by-sides, utility vehicles, personal transportation vehicles and aviation ground support equipment. We build thousands of vehicles each year, many of which featuring game-changing technology and innovations to improve vehicle efficiency and enhance the user experience like no other vehicle can. Today, Textron Specialized Vehicles includes brands that are leaders in the respective industries they serve -- Cushman®, E-Z-GO®, Arctic Cat®, Jacobsen®, Ransomes®, TUG™, Douglas™, Premier™, and Safeaero™. Since 1960, the company has been part of Textron Inc. (NYSE: TXT), a global multi-industry company headquartered in Providence, RI. A Fortune 500 company with more than 35,000 employees worldwide and operations in 25 countries, Textron is known for its powerful brands, including E-Z-GO, Cessna, Beechcraft, Hawker, Bell, and Kautex, among others. But nearly 70 years after our first product was built in that one-room shop, there is still that single belief – that we exist to build vehicles and services that exceed customers expectations, better than any other offering on the market. It is the drive to sustain and improve that position – to offer an unparalleled combination of world-class products, advanced technology, manufacturing expertise, and extraordinary service – that leads Textron Specialized Vehicles to cover new ground.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.